Publication not explained
Read the Original
This page is a summary of: The Inhibition of Mammalian 15-Lipoxygenases by the Anti-Inflammatory Drug Ebselen: Dual-Type Mechanism Involving Covalent Linkage and Alteration of the Iron Ligand Sphere, Molecular Pharmacology, July 1999, American Society for Pharmacology & Experimental Therapeutics (ASPET), DOI: 10.1124/mol.56.1.196.
You can read the full text:
Be the first to contribute to this page